Report urges Canada to beef up IP protection for biologics
Intellectual property protection for biologic medicines in Canada falls far behind that in other countries, a new report from the Fraser Institute has found. Biologics’ intellectual property includes both the chemical structure of the molecule and the process for manufacturing it in living tissues, so product patents alone aren’t enough to protect and incentivize their […]
- July 12, 2016 September 13, 2019
- 11:23